Rosty Raykov - Jan 6, 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Rosty Raykov
Stock symbol
FENC
Transactions as of
Jan 6, 2025
Transactions value $
-$60,800
Form type
4
Date filed
1/7/2025, 05:15 PM
Previous filing
Jan 3, 2025
Next filing
Feb 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale -$14.8K -2.43K -2.59% $6.08 91.4K Jan 6, 2025 Direct F1
transaction FENC Common shares Sale -$46K -7.57K -8.28% $6.08 83.9K Jan 6, 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
F2 Shares acquired through the exercise of an option contract with strike price of $2.36 on August 13, 2020.